Literature DB >> 7919729

Surgical results of performing R4 gastrectomy for gastric cancer located in the upper third of the stomach.

Y Yonemura1, M Segawa, H Matsumoto, K Tsugawa, I Ninomiya, L Fonseca, T Fujimura, K Sugiyama, K Miwa, I Miyazaki.   

Abstract

Because gastric cancers located in the upper third of the stomach are difficult to detect at an early stage, the surgical results remain poor. We performed R4 gastrectomy as a radical procedure for 25 patients, involving complete resection of the latero-aortic and interaorticovenous lymph modes above and below the left renal vein, in combination with the ordinary R2 or R3 gastrectomy (the R4 group). These patients were compared with 156 others who underwent R2 gastrectomy alone (the R2 group). There were no significant differences in operation time, blood loss, or the incidence of complications between the two groups; however, when the survival rates of the patients with tumors invading beyond the subserosa were compared, the 5-year survival rate was found to be significantly higher in the R4 group than in the R2 group. Furthermore, in patients with para-aortic nodal involvement, a significant survival advantage was observed in the R4 group, as compared with the R2 group. These results suggest that the R4 gastrectomy is a rational approach for patients with advanced gastric cancer located in the upper third of the stomach.

Entities:  

Mesh:

Year:  1994        PMID: 7919729     DOI: 10.1007/bf01884566

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  13 in total

1.  Lymph node metastases of gastric cancer. General pattern in 1931 patients.

Authors:  K Maruyama; P Gunvén; K Okabayashi; M Sasako; T Kinoshita
Journal:  Ann Surg       Date:  1989-11       Impact factor: 12.969

2.  Randomized comparison of R1 and R2 gastrectomy for gastric carcinoma.

Authors:  D M Dent; M V Madden; S K Price
Journal:  Br J Surg       Date:  1988-02       Impact factor: 6.939

3.  Progress in gastric cancer surgery in Japan and its limits of radicality.

Authors:  K Maruyama; K Okabayashi; T Kinoshita
Journal:  World J Surg       Date:  1987-08       Impact factor: 3.352

4.  Results of gastric resection for carcinoma of the stomach: the European experience.

Authors:  G Heberer; R K Teichmann; H J Krämling; B Günther
Journal:  World J Surg       Date:  1988-06       Impact factor: 3.352

5.  [Studies on para-aortic metastatic lymph nodes in gastric cancer after endoscopic injection of activated carbon particles].

Authors:  S Takahashi; T Takahashi; K Sawai; A Hagiwara; H Tokuda; G Kato; A Takenaka
Journal:  Nihon Geka Gakkai Zasshi       Date:  1987-01

6.  Pancreaticoduodenectomy in combination with right hemicolectomy for surgical treatment of advanced gastric carcinoma located in the lower half of the stomach.

Authors:  Y Yonemura; S Ooyama; H Matumoto; T Kamata; H Kimura; S Takegawa; T Kosaka; A Yamaguchi; K Miwa; I Miyazaki
Journal:  Int Surg       Date:  1991 Oct-Dec

7.  Gastric cancer: an audit of 122 consecutive cases and the results of R1 gastrectomy.

Authors:  T T Irvin; J E Bridger
Journal:  Br J Surg       Date:  1988-02       Impact factor: 6.939

8.  The general rules for the gastric cancer study in surgery and pathology. Part I. Clinical classification.

Authors:  T Kajitani
Journal:  Jpn J Surg       Date:  1981-03

9.  Influence of the extent of resection on survival after curative treatment of gastric carcinoma. A retrospective multivariate analysis.

Authors:  M H Shiu; E Moore; M Sanders; A Huvos; B Freedman; J Goodbold; S Chaiyaphruk; R Wesdorp; M F Brennan
Journal:  Arch Surg       Date:  1987-11

10.  Surgical treatment of advanced gastric cancer with metastasis in para-aortic lymph node.

Authors:  Y Yonemura; K Katayama; T Kamata; S Fushida; M Segawa; S Ooyama; K Miwa; I Miyazaki
Journal:  Int Surg       Date:  1991 Oct-Dec
View more
  4 in total

1.  Is the length of esophageal invasion only associated with mediastinal nodal metastasis from adenocarcinoma of the esophagogastric junction (Siewert type II and III) after neo-adjuvant chemoradiotherapy?

Authors:  Shinji Mine
Journal:  J Thorac Dis       Date:  2019-10       Impact factor: 2.895

2.  Randomized clinical trial of D2 and extended paraaortic lymphadenectomy in patients with gastric cancer.

Authors:  Yutaka Yonemura; Cheng-Chung Wu; Norimasa Fukushima; Ichirou Honda; Etsurou Bandou; Taiichi Kawamura; Tohru Kamata; Byung-Sik Kim; Nobuo Matsuki; Toshiharu Sawa; Sung-Hoon Noh
Journal:  Int J Clin Oncol       Date:  2008-05-08       Impact factor: 3.402

Review 3.  Changing Trends in Gastric Cancer Surgery.

Authors:  İlter Özer; Erdal Birol Bostancı; Murat Ulaş; Yusuf Özoğul; Musa Akoğlu
Journal:  Balkan Med J       Date:  2017-01-05       Impact factor: 2.021

4.  Propensity-score-matching-based analysis of laparoscopic gastrectomy with neoadjuvant chemotherapy for gastric carcinoma.

Authors:  Shimpei Furuta; Ichiro Uyama; Zenichi Morise
Journal:  Fujita Med J       Date:  2020-10-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.